Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift
Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis...
Gespeichert in:
| Veröffentlicht in: | Clinical radiology 2021-05, Vol.76 (5), p.391.e1-391.e18 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 391.e18 |
|---|---|
| container_issue | 5 |
| container_start_page | 391.e1 |
| container_title | Clinical radiology |
| container_volume | 76 |
| creator | Zafar, S. Sharma, R.K. Cunningham, J. Mahalingam, P. Attygalle, A.D. Khan, N. Cunningham, D. El-Sharkawi, D. Iyengar, S. Sharma, B. |
| description | Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis, which contributes adversely to patient morbidity and mortality. This article will address relevant imaging aspects, with particular reference to advancements in NHL imaging, including computed tomography (CT), integrated positron-emission tomography (PET)-CT, and magnetic resonance imaging (MRI). We provide multiparametric (anato-functional) imaging display items, including histological correlation. We will also introduce our original concept of “Specialist Integrated Haematological Malignancy Imaging Reporting” (SIHMIR), a paradigm shift in lymphoma radiology. |
| doi_str_mv | 10.1016/j.crad.2020.12.022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2489261917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926021000179</els_id><sourcerecordid>2489261917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-3233aaaba84edb2321a0ebeed9ea6831a3d5c31455db5920d8bdf5012af467813</originalsourceid><addsrcrecordid>eNp9kc-O0zAQxiMEYsvCC3BAvrFIpPhPkjaIC6oWWmkXpF2QuFkTe5K6JHawnZX6hjwWjlo4cvJ49JtvNN-XZS8ZXTLKqneHpfKgl5zy1OBLyvmjbMFEVeac1z8eZwtKaZ3XvKIX2bMQDvO34MXT7EKIclWXbLXIfm8m79FGAlaTdoqTR9JgiGT0oKJRSIwlZoDO2O4tCfFczLTHMDobkEAIGMIwq7TOky_O5lunu5_Gvg6kPw7j3g0Q3pO4R3I_ojLQm7RhZyN2HiJqsgUcILredUZBT24T0Fmw6kh2p9XkDkfn41xd3e-2t7u7N2SEdL3pBhL2po3Psyct9AFfnN_L7Pun62-bbX7z9fNu8_EmV6KsYi64EADQwLpA3XDBGVBsEHWNUK0FA6FLJVhRlropa071utFtSRmHtqhWayYus6uT7ujdryk5JQcTFPY9WHRTkLxYJ8dZzVYJ5SdUeReCx1aOPlnpj5JROScoD3JOUM4JSsZlSjANvTrrT82A-t_I38gS8OEEYLrywaCXQRm0CrXxqKLUzvxP_w9SW7Do</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489261917</pqid></control><display><type>article</type><title>Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift</title><source>Access via ScienceDirect (Elsevier)</source><creator>Zafar, S. ; Sharma, R.K. ; Cunningham, J. ; Mahalingam, P. ; Attygalle, A.D. ; Khan, N. ; Cunningham, D. ; El-Sharkawi, D. ; Iyengar, S. ; Sharma, B.</creator><creatorcontrib>Zafar, S. ; Sharma, R.K. ; Cunningham, J. ; Mahalingam, P. ; Attygalle, A.D. ; Khan, N. ; Cunningham, D. ; El-Sharkawi, D. ; Iyengar, S. ; Sharma, B.</creatorcontrib><description>Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis, which contributes adversely to patient morbidity and mortality. This article will address relevant imaging aspects, with particular reference to advancements in NHL imaging, including computed tomography (CT), integrated positron-emission tomography (PET)-CT, and magnetic resonance imaging (MRI). We provide multiparametric (anato-functional) imaging display items, including histological correlation. We will also introduce our original concept of “Specialist Integrated Haematological Malignancy Imaging Reporting” (SIHMIR), a paradigm shift in lymphoma radiology.</description><identifier>ISSN: 0009-9260</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/j.crad.2020.12.022</identifier><identifier>PMID: 33579517</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Clinical radiology, 2021-05, Vol.76 (5), p.391.e1-391.e18</ispartof><rights>2021 The Royal College of Radiologists</rights><rights>Copyright © 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-3233aaaba84edb2321a0ebeed9ea6831a3d5c31455db5920d8bdf5012af467813</citedby><cites>FETCH-LOGICAL-c356t-3233aaaba84edb2321a0ebeed9ea6831a3d5c31455db5920d8bdf5012af467813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.crad.2020.12.022$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33579517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zafar, S.</creatorcontrib><creatorcontrib>Sharma, R.K.</creatorcontrib><creatorcontrib>Cunningham, J.</creatorcontrib><creatorcontrib>Mahalingam, P.</creatorcontrib><creatorcontrib>Attygalle, A.D.</creatorcontrib><creatorcontrib>Khan, N.</creatorcontrib><creatorcontrib>Cunningham, D.</creatorcontrib><creatorcontrib>El-Sharkawi, D.</creatorcontrib><creatorcontrib>Iyengar, S.</creatorcontrib><creatorcontrib>Sharma, B.</creatorcontrib><title>Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift</title><title>Clinical radiology</title><addtitle>Clin Radiol</addtitle><description>Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis, which contributes adversely to patient morbidity and mortality. This article will address relevant imaging aspects, with particular reference to advancements in NHL imaging, including computed tomography (CT), integrated positron-emission tomography (PET)-CT, and magnetic resonance imaging (MRI). We provide multiparametric (anato-functional) imaging display items, including histological correlation. We will also introduce our original concept of “Specialist Integrated Haematological Malignancy Imaging Reporting” (SIHMIR), a paradigm shift in lymphoma radiology.</description><issn>0009-9260</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc-O0zAQxiMEYsvCC3BAvrFIpPhPkjaIC6oWWmkXpF2QuFkTe5K6JHawnZX6hjwWjlo4cvJ49JtvNN-XZS8ZXTLKqneHpfKgl5zy1OBLyvmjbMFEVeac1z8eZwtKaZ3XvKIX2bMQDvO34MXT7EKIclWXbLXIfm8m79FGAlaTdoqTR9JgiGT0oKJRSIwlZoDO2O4tCfFczLTHMDobkEAIGMIwq7TOky_O5lunu5_Gvg6kPw7j3g0Q3pO4R3I_ojLQm7RhZyN2HiJqsgUcILredUZBT24T0Fmw6kh2p9XkDkfn41xd3e-2t7u7N2SEdL3pBhL2po3Psyct9AFfnN_L7Pun62-bbX7z9fNu8_EmV6KsYi64EADQwLpA3XDBGVBsEHWNUK0FA6FLJVhRlropa071utFtSRmHtqhWayYus6uT7ujdryk5JQcTFPY9WHRTkLxYJ8dZzVYJ5SdUeReCx1aOPlnpj5JROScoD3JOUM4JSsZlSjANvTrrT82A-t_I38gS8OEEYLrywaCXQRm0CrXxqKLUzvxP_w9SW7Do</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Zafar, S.</creator><creator>Sharma, R.K.</creator><creator>Cunningham, J.</creator><creator>Mahalingam, P.</creator><creator>Attygalle, A.D.</creator><creator>Khan, N.</creator><creator>Cunningham, D.</creator><creator>El-Sharkawi, D.</creator><creator>Iyengar, S.</creator><creator>Sharma, B.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift</title><author>Zafar, S. ; Sharma, R.K. ; Cunningham, J. ; Mahalingam, P. ; Attygalle, A.D. ; Khan, N. ; Cunningham, D. ; El-Sharkawi, D. ; Iyengar, S. ; Sharma, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-3233aaaba84edb2321a0ebeed9ea6831a3d5c31455db5920d8bdf5012af467813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zafar, S.</creatorcontrib><creatorcontrib>Sharma, R.K.</creatorcontrib><creatorcontrib>Cunningham, J.</creatorcontrib><creatorcontrib>Mahalingam, P.</creatorcontrib><creatorcontrib>Attygalle, A.D.</creatorcontrib><creatorcontrib>Khan, N.</creatorcontrib><creatorcontrib>Cunningham, D.</creatorcontrib><creatorcontrib>El-Sharkawi, D.</creatorcontrib><creatorcontrib>Iyengar, S.</creatorcontrib><creatorcontrib>Sharma, B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zafar, S.</au><au>Sharma, R.K.</au><au>Cunningham, J.</au><au>Mahalingam, P.</au><au>Attygalle, A.D.</au><au>Khan, N.</au><au>Cunningham, D.</au><au>El-Sharkawi, D.</au><au>Iyengar, S.</au><au>Sharma, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift</atitle><jtitle>Clinical radiology</jtitle><addtitle>Clin Radiol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>76</volume><issue>5</issue><spage>391.e1</spage><epage>391.e18</epage><pages>391.e1-391.e18</pages><issn>0009-9260</issn><eissn>1365-229X</eissn><abstract>Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis, which contributes adversely to patient morbidity and mortality. This article will address relevant imaging aspects, with particular reference to advancements in NHL imaging, including computed tomography (CT), integrated positron-emission tomography (PET)-CT, and magnetic resonance imaging (MRI). We provide multiparametric (anato-functional) imaging display items, including histological correlation. We will also introduce our original concept of “Specialist Integrated Haematological Malignancy Imaging Reporting” (SIHMIR), a paradigm shift in lymphoma radiology.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33579517</pmid><doi>10.1016/j.crad.2020.12.022</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9260 |
| ispartof | Clinical radiology, 2021-05, Vol.76 (5), p.391.e1-391.e18 |
| issn | 0009-9260 1365-229X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2489261917 |
| source | Access via ScienceDirect (Elsevier) |
| title | Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A05%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20and%20future%20best%20practice%20in%20imaging,%20staging,%20and%20response%20assessment%20for%20Non-Hodgkin's%20lymphomas:%20the%20Specialist%20Integrated%20Haematological%20Malignancy%20Imaging%20Reporting%20(SIHMIR)%20paradigm%20shift&rft.jtitle=Clinical%20radiology&rft.au=Zafar,%20S.&rft.date=2021-05&rft.volume=76&rft.issue=5&rft.spage=391.e1&rft.epage=391.e18&rft.pages=391.e1-391.e18&rft.issn=0009-9260&rft.eissn=1365-229X&rft_id=info:doi/10.1016/j.crad.2020.12.022&rft_dat=%3Cproquest_cross%3E2489261917%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489261917&rft_id=info:pmid/33579517&rft_els_id=S0009926021000179&rfr_iscdi=true |